Silence Therapeutics (United Kingdom)
Silence Therapeutics, is a London-based pharmaceutical company formed in 1994. The company since its inception has pioneered the design and development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Silence Therapeutics (United Kingdom), United Kingdom, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
64%
Total
Publications
92
Total Open
Publications
59
Total
Citations
2.3K
Open Access
Percentage
64%
Total
Publications
92
Total Open
Publications
59
Total
Citations
2.3K
Breakdown
Publisher Open
15%
Both
46%
Other Platform Open
3%
Closed
36%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
16
Hybrid 30%
17
No Guarantees 41%
23
Other Platform Open
Domain 82%
37
Institution 40%
18
Preprint 9%
4
Public 9%
4
Other Internet 9%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 37 |
Europe PMC | Domain | 16 |
Figshare | Public | 14 |
University College London - UCL Discovery | Institution | 4 |
University of East Anglia - UEA Digital Repository | Institution | 3 |
bioRxiv | Preprint | 3 |
University of the Basque Country - Communities in ADDI | Institution | 2 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
Spanish National Research Council (CSIC) - DIGITAL.CSIC | Institution | 2 |